e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Tuberculosis and HIV coinfection
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
CCR5 ligands expression in lungs is affected by latent tuberculosis and HIV-coinfection
B. Kalsdorf, K. Skolimowska, T. J. Scriba, R. Dawson, K. Wood, J. Hofmeister, C. Lange, R. J. Wilkinson (Cape Town, South Africa; , Germany; London, United Kingdom)
Source:
Annual Congress 2010 - Tuberculosis and HIV coinfection
Session:
Tuberculosis and HIV coinfection
Session type:
Oral Presentation
Number:
3861
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Kalsdorf, K. Skolimowska, T. J. Scriba, R. Dawson, K. Wood, J. Hofmeister, C. Lange, R. J. Wilkinson (Cape Town, South Africa; , Germany; London, United Kingdom). CCR5 ligands expression in lungs is affected by latent tuberculosis and HIV-coinfection. Eur Respir J 2010; 36: Suppl. 54, 3861
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
The impact of anti-IgE treatment on the airway microbiome in asthma.
Occupational and drug-induced ILDs
Related content which might interest you:
Increased cell expression of CCR5 during M. tuberculosis infection
Source: ISSN=ISSN 1810-6838, ISBN=, page=177
Year: 2005
Expansion of CCR5+ CD4+ T-lymphocytes in the course of active pulmonary tuberculosis
Source: Eur Respir J 2004; 24 : 638-643
Year: 2004
Expression of the PDCD1 gene to determine active tuberculosis infection in children and adolescents with latent TB infection
Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis
Year: 2020
Cytokines/chemokines gene expression in the lungs of fibrous-cavernous TB patients.
Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools
Year: 2018
Antigen specific CD4 and CD8 signatures of different Mycobacterium tuberculosis (MTB) infection phases
Source: Annual Congress 2010 - Tuberculosis: from bench to bedside
Year: 2010
Utility of mycobacterium tuberculosis Rv0081-specific host gene expression to distinguish latent infection from active tuberculosis disease
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016
Increased frequencies of pulmonary regulatory T-cells in latent Mycobacterium tuberculosis infection
Source: Eur Respir J 2012; 40: 1450-1457
Year: 2012
Comparison of effector T-cell responses in patients with active TB disease compared to latent TB infection
Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease
Year: 2007
Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection
Source: Eur Respir J 2010; 35: 619-626
Year: 2010
Toll-like receptor polymorphisms associated with progression of
Mycobacterium tuberculosis
infection to pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 142s
Year: 2006
Comparison of Nramp1 gene polymorphisms among tuberculosis healthy workers with positive PPD and recently infected cases; host susceptibility to tuberculosis
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008
IFN-γ, IP-10 and MCP-2 response to RD1 selected peptides are associated with active tuberculosis
Source: Annual Congress 2010 - Scientific advances in tuberculosis
Year: 2010
The change of PD-1 and CTLA-4 during LTBI and TB reactivation
Source: International Congress 2019 – Tuberculosis: diagnosis and scores
Year: 2019
Loss of receptors CD27 and CCR7 on Mycobacterium tuberculosis-specific interferon-γ producing T cells marks active tuberculosis
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009
Different genetics background of patients with latent tuberculosis infection versus active tuberculosis
Source: International Congress 2017 – Asthma genetics and genomics in patients and populations
Year: 2017
The study of differential gene expression of matrix metalloproteinases in macrophages infected with Mycobacterium tuberculosis
Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools
Year: 2018
CCR5-Δ32 deletion and CCL5 polymorphisms in tuberculosis susceptibility
Source: Annual Congress 2010 - Scientific advances in tuberculosis
Year: 2010
Immunological differences between lung tuberculosis and latent tuberculosis infection
Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools
Year: 2018
Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of infection with mycobacterium tuberculosis
Source: Annual Congress 2008 - New methods to diagnose tuberculosis infection and disease
Year: 2008
Evaluating the use of the interferon-γ response to mycobacterium tuberculosis (MTB) specific antigens to diagnose latent tuberculosis infection in patients with chronic inflammatory joint and skin diseases
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept